Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Simona Degli Esposti is active.

Publication


Featured researches published by Simona Degli Esposti.


PLOS ONE | 2013

Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)

Sobha Sivaprasad; Roxanne Crosby-Nwaobi; Simona Degli Esposti; Tunde Peto; Ranjan Rajendram; Michel Michaelides; Philip Hykin

Background To describe structural and functional changes associated with diabetic macular oedema (DMO) treated with intravitreal bevacizumab over 24 months. Methods A post-hoc analysis of the data of 34 patients that completed 24 months follow-up in the intravitreal bevacizumab arm of a prospective, randomized controlled trial (BOLT study) was performed. The outcome measures previously used in clinical trials of intravitreal ranibizumab in DMO were employed to describe the visual acuity and macular thickness changes at 12 and 24 months. Results The standard outcomes of mean change in best corrected visual acuity (BCVA) and central macular thickness (CMT) in participants treated with bevacizumab were comparable to those reported in association with ranibizumab. However, exploratory analyses showed that thick maculae at baseline defined as CMT of ≥400 µm, remained significantly thicker than those <400 µm with intensive bevacizumab therapy, despite a comparable gain in visual acuity at both 12 and 24 months. The proportion of subjects that attained a dry macula doubled in both CMT groups between the 12 and 24-month time-points. Conclusions These findings provide valuable information both for clinical practice and trials. Further studies are required to investigate the impact of intravitreal bevacizumab on retinal thickness profiles in DMO.


Ocular Immunology and Inflammation | 2017

The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends

Aniruddha Agarwal; Rupesh Agrawal; Dinesh Visva Gunasekaran; Dhananjay Raje; Bhaskar Gupta; Kanika Aggarwal; Somasheila L. Murthy; Mark Westcott; Soon Phaik Chee; Peter McCluskey; H. Su Ling; Stephen C. Teoh; Luca Cimino; Jyotirmay Biswas; Shishir Narain; Manisha Agarwal; Padmamalini Mahendradas; Moncef Khairallah; Nicholas Jones; Ilknur Tugal-Tutkun; Kalpana Babu; Soumayava Basu; Ester Carreño; Richard W J Lee; Hassan Al-Dhibi; Bahram Bodaghi; Alessandro Invernizzi; Debra A. Goldstein; Carl P. Herbort; Talin Barisani-Asenbauer

ABSTRACT Purpose: To analyze the role of polymerase chain reaction (PCR) of ocular fluids in management of tubercular (TB) anterior, intermediate, posterior, and panuveitis. Methods: In Collaborative Ocular Tuberculosis Study (COTS)-1 (25 centers, n = 962), patients with TB-related uveitis were included. 59 patients undergoing PCR of intraocular fluids (18 females; 53 Asian Indians) were included. Results: 59 (6.13%) of COTS-1 underwent PCR analysis. PCR was positive for Mycobacterium TB in 33 patients (23 males; all Asian Indians). 26 patients were PCR negative (18 males). Eight patients with negative PCR had systemic TB. Anti-TB therapy was given in 18 negative and 31 PCR cases. At 1-year follow-up, five patients with positive PCR (15.15%) and three with negative PCR (11.54%) had persistence/worsening of inflammation. Conclusions: Data from COTS-1 suggest that PCR is not commonly done for diagnosing intraocular TB and positive/negative results may not influence management or treatment outcomes in the real world scenario.


Retina-the Journal of Retinal and Vitreous Diseases | 2017

ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE–FUNCTION CORRELATION

Mali Okada; Anthony G. Robson; Catherine Egan; Ferenc B. Sallo; Simona Degli Esposti; Tjebo F. C. Heeren; Marcus Fruttiger; Graham E. Holder

Purpose: To investigate the electrophysiological features of macular telangiectasia Type 2 and their relationship to structure as determined by optical coherence tomography imaging. Methods: Forty-two eyes from 21 patients enrolled in the Macular Telangiectasia Natural History Observation Study were reviewed. All patients had full-field and pattern electroretinography (ERG; PERG) with some patients additionally having multifocal electroretinography (mfERG; N = 15) or electrooculography (N = 12). Multiple linear regression modeling assessed the relationship between the ellipsoid zone break size on optical coherence tomography and the central mfERG response. Results: Full-field ERG and electrooculography were normal in all eyes. Six eyes (14%) from five patients had subnormal PERG P50 amplitudes. Twenty-two of 30 eyes (73%) had reduced central or paracentral stimulus on mfERG. There was a significant correlation between ellipsoid zone break size and both the P1 amplitude (R2 = 0.37, P = 0.002) and P1:N1 ratio (R2 = 0.32, P = 0.002) of the central response on mfERG. Conclusion: The electrophysiological findings in macular telangiectasia Type 2 are those of localized central dysfunction and are consistent with the structural data available from imaging and histologic studies. The ellipsoid zone break size correlates with mfERG reduction. The reduced mfERG P1:N1 ratio is consistent with inner retinal dysfunction.


Archives of Ophthalmology | 2012

A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema: 24-Month Data: Report 3

Ranjan Rajendram; Samantha Fraser-Bell; Andrew Kaines; Michel Michaelides; Robin Hamilton; Simona Degli Esposti; Tunde Peto; Catherine Egan; Catey Bunce; Richard David Leslie; Philip Hykin


Investigative Ophthalmology & Visual Science | 2012

Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.

Simona Degli Esposti; Catherine Egan; Catey Bunce; J. D. Moreland; Alan C. Bird; Anthony G. Robson


Investigative Ophthalmology & Visual Science | 2012

Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects

Simona Degli Esposti; Catherine Egan; Catey Bunce; J. D. Moreland; Alan C. Bird; Anthony G. Robson


Archive | 2017

A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema

Ranjan Rajendram; Samantha Fraser-Bell; Andrew Kaines; Michel Michaelides; Robin Hamilton; Simona Degli Esposti; Tunde Peto; Catherine Egan; Catey Bunce; Richard David Leslie; Philip Hykin


Investigative Ophthalmology & Visual Science | 2016

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Ferenc B. Sallo; Irene Leung; Simona Degli Esposti; Traci E. Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C. Bird; Tunde Peto


Ocular Immunology and Inflammation | 2018

The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis

Rupesh Agrawal; Dinesh Visva Gunasekeran; Aniruddha Agarwal; Ester Carreño; Kanika Aggarwal; Bhaskar Gupta; Dhananjay Raje; Somasheila I. Murthy; Mark Westcott; Soon Phaik Chee; Peter McCluskey; Ho Su Ling; Stephen C. Teoh; Luca Cimino; Jyotirmay Biswas; Shishir Narain; Manisha Agarwal; Padmamalini Mahendradas; Moncef Khairallah; Nicholas Jones; Ilknur Tugal-Tutkun; Kalpana Babu; Soumayava Basu; Richard W J Lee; Hassan Al-Dhibi; Bahram Bodaghi; Alessandro Invernizzi; Debra A. Goldstein; Carl P. Herbort; Talin Barisani-Asenbauer


Investigative Ophthalmology & Visual Science | 2017

Optical coherence tomography angiography in treated neovascular age related macular degeneration

Maria K Gemenetzi; Maria Eleftheriadou; Simona Degli Esposti; Zaria Ali; Daren Hanumunthadu; Konstantinos Balaskas; Praveen J. Patel

Collaboration


Dive into the Simona Degli Esposti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adnan Tufail

Moorfields Eye Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dawn A. Sim

Moorfields Eye Hospital

View shared research outputs
Top Co-Authors

Avatar

Tunde Peto

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

Alan C. Bird

Moorfields Eye Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge